urapidil has been researched along with Ischemia in 4 studies
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is one of the major cardiovascular risk factors." | 2.68 | [Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study]. ( Allaert, FA; Barrier, J; Blétry, O; Chamontin, B; Devulder, B; Godeau, P; Godin, M; Guillevin, L; Guilmot, JL; Luccioni, R, 1995) |
| "Hypertension is one of the major cardiovascular risk factors." | 1.29 | [Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)]. ( Allaert, FA; Barrier, J; Blétry, O; Chamontin, B; Devulder, B; Godeau, P; Godin, M; Guillevin, L; Guilmot, JL; Luccioni, R; Ninet, J; Serise, JM; Zannad, FM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peruche, B | 1 |
| Backhauss, C | 1 |
| Prehn, JH | 1 |
| Krieglstein, J | 1 |
| Godeau, P | 2 |
| Allaert, FA | 2 |
| Barrier, J | 2 |
| Blétry, O | 2 |
| Chamontin, B | 2 |
| Devulder, B | 2 |
| Godin, M | 2 |
| Guillevin, L | 2 |
| Guilmot, JL | 2 |
| Luccioni, R | 2 |
| Ninet, J | 1 |
| Serise, JM | 1 |
| Zannad, FM | 1 |
| Eckert, RE | 1 |
| Karsten, AJ | 1 |
| Utz, J | 1 |
| Ziegler, M | 1 |
1 trial available for urapidil and Ischemia
| Article | Year |
|---|---|
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study].
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Brain Ischemia; Cardiovascular Diseases; Drug Ther | 1995 |
3 other studies available for urapidil and Ischemia
| Article | Year |
|---|---|
Protective effects of 5-HT1A receptor agonists against neuronal damage demonstrated in vivo and in vitro.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Chick Embryo; Glutamic Acid; In Vitro Techniques; Ischemia; | 1994 |
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)].
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Drug Evaluation; Electrocardiography; Female | 1996 |
Regulation of renal artery smooth muscle tone by alpha1-adrenoceptors: role of voltage-gated calcium channels and intracellular calcium stores.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium Channel Blockers; | 2000 |